Atrial Fibrillation and Ischemic Events With Rivaroxaban in Patients With Stable Coronary Artery Disease Study

NCT02642419 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

2200

Enrollment

OTHER

Sponsor class

Conditions

Atrial Fibrillation

Interventions

DRUG: Rivaroxaban and single antiplatelet drug (aspirin, clopidogrel or prasugrel)
DRUG: Rivaroxaban

Sponsor

Japan Cardiovascular Research Foundation